FAKTOR OPTIONSSCHEIN - MERCK & CO. Stock

Certificat

DE000UM2AXM2

Market Closed - Boerse Frankfurt Warrants 13:25:19 2024-06-04 EDT
4.01 EUR -1.47% Intraday chart for FAKTOR OPTIONSSCHEIN - MERCK & CO.
Current month-12.64%
1 month-6.53%
Date Price Change
24-06-04 4.01 -1.47%
24-06-03 4.07 -11.33%
24-05-31 4.59 +10.60%
24-05-30 4.15 -7.16%
24-05-29 4.47 +1.13%

Real-time Boerse Frankfurt Warrants

Last update June 04, 2024 at 01:25 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer UBS
WKN UM2AXM
ISINDE000UM2AXM2
Date issued 2024-02-06
Strike 154.1 $
Maturity Unlimited
Parity 5.83 : 1
Emission price 5.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.12
Lowest since issue 3.48
Spread 0.1
Spread %2.46%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7 USD
Average target price
142.2 USD
Spread / Average Target
+10.48%
Consensus